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Topical testosterone gels are now a widely used method of
testosterone replacement therapy and have been shown to
be convenient and effective [1]. The unintentional transfer
of testosterone gel to children or partners by skin contact
is a rare but significant adverse effect [2].
A 3-year-old well girl was referred for assessment of
precocious puberty. Pubic hair had been first noted by
her mother 9 months earlier. Examination revealed a
tall girl (>99.9th centile) with no breast development but
Tanner stage III pubic hair and cliteromegaly. Testoster-
one levels were elevated at 2.5nmol/l, as was her
Androstenedione level at 1.1nmol/l. 17 OH P was nor-
mal and tumour markers were negative. Urine steroid
profile was quantitatively normal but there was a mod-
est increase in androgen metabolites. Bone age was
advanced by 16 months. Ultrasound and MRI imaging
of her ovaries and adrenals did not reveal a source of
androgen production.
Upon further direct questioning, her father revealed he
was using topical testosterone replacement therapy. Her
father was advised of measures to reduce secondary expo-
sure. Her repeat testosterone level fell to <0.7 nmol/l upon
retesting 4 months later and the cliteromegaly resolved. At
follow up a further six months later, testosterone level had
risen to 2.5nmol/l. Switching to the use of IM preparations
was encouraged. Follow-up testing after these measures
were adopted revealed normal undetectable testosterone
levels (<0.7nmol/l).
Once daily application of testosterone gels to the skin
results in relatively stable and physiological testosterone
levels in most users[3]. It is often favoured above the
other methods of delivery of testosterone as it is painless,
discrete and convenient to use. Even small quantities of
transferred testosterone may result in clinical signs of
hyperandrogenism.
When reviewing children with evidence of virilization,
we must remember to question parents about the
potential for exogenous androgen exposure.
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